Spine BioPharma, Inc.SB
SEC Form D filing

Spine BioPharma, Inc.

Biotech · Series A · Regulation D 506(b) · NY · Filed June 5, 2026

Offering amount
$8.5M
Exemption
Reg D 506(b)
Issuer state
NY
Filing date
June 5, 2026
Signature date
June 5, 2026
CIK
0001852647

Summary

Auto-generated

biotech company developing spinal therapies, raising $8.5M Series A in NY

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.